dr-kunjahari-medhi
Verified Specialist
Senior Hematologist & BMT Expert

Dr. Kunjahari Medhi

MBBS  ·  MD / MS  ·  Super-Specialty Fellowship
Senior Director Medical Oncology & Hemato-oncology
Medanta Cancer Institute, Gurugram, Gurugram
Bone Marrow TransplantCAR T-cell TherapyBlood CancerStem Cell TransplantThalassemiaAplastic AnaemiaLymphoma
Dr Kunjahari Medhi will review your reports before recommending a treatment plan
20+ YearsClinical Hematology & Oncology
1,500+BMT & Stem Cell Transplants
>90%Treatment Success Rate
Blood DisordersLymphoma · Leukemia · BMT · CAR-T
About the Doctor

About Dr. Kunjahari Medhi

Dr. Kunjahari Medhi is a senior Medical Oncologist and Haemato-Oncology specialist serving as Vice Chairman of Medical Oncology and Haemato-Oncology at Medanta – The Medicity, Gurugram. His clinical practice focuses on the diagnosis and treatment of solid tumours and blood-related malignancies in adult and paediatric patients.

He completed his DM in Medical Oncology from the All India Institute of Medical Sciences (AIIMS), New Delhi, in January 2007. He subsequently worked as a Senior Research Associate in Medical Oncology at AIIMS under the Council of Scientific and Industrial Research (CSIR). He also received advanced clinical research training at Oxford University, United Kingdom, through the INDOX Fellowship.

His clinical expertise includes chemotherapy, immunotherapy, targeted therapy, hormonal therapy and biological treatments for different malignancies. He also manages haematological cancers, including leukaemias and lymphomas, alongside solid tumour oncology and other complex cancer conditions.

Dr. Medhi has contributed to oncology research and clinical education through his academic work and professional training. He has also completed executive education in the advanced management of oncological diseases through Harvard Medical School, strengthening his background in modern cancer management and specialist oncology leadership.

Education & Training

MBBSBachelor of Medicine & Surgery from a premier medical institution in India
MD / MS — Post-Graduate SpecialisationPost-graduate degree in Hematology & BMT from a nationally recognised institution
Fellowship & Super-SpecialisationAdvanced fellowship training at leading national and international centres of excellence

Recognitions

International Patient Excellence AwardRecognised for outstanding care delivered to international patients from 50+ countries
Best Doctor in Hematology & BMTPeer-voted recognition for clinical excellence and patient outcomes
Member — National & International Medical SocietiesActive member of leading medical associations in Hematology & BMT
Why Dr. Kunjahari Medhi

Why Choose Dr. Kunjahari Medhi?

Decades of expertise, proven results, and compassionate care — here is why patients from 50+ countries trust Dr. Kunjahari Medhi for Hematology & BMT treatment in India.

20+Years
5,000+Procedures
50+Countries
01

Highly Experienced Hematology & BMT Specialist

Over 20 years of dedicated clinical experience with 5,000+ procedures. One of the most trusted names in Hematology & BMT in India.

02

Trusted by International Patients

Dr. Kunjahari Medhi regularly treats patients from Africa, the Middle East, Central Asia, and Europe. Dedicated international patient support team available 24/7.

03

JCI & NABH Accredited Hospital

Practices at an internationally accredited hospital, ensuring patient safety standards that match the best hospitals in the USA and Europe.

04

60-80% Lower Cost Than Western Countries

World-class treatment at a fraction of USA, UK, or Australian prices. Transparent cost estimates provided before you travel.

05

Advanced Training & Internationally Recognised

Dr. Kunjahari Medhi holds postgraduate qualifications from premier Indian institutions and has advanced fellowship training in Hematology & BMT.

06

Personalised, Patient-First Approach

Every case is personally reviewed. Treatment plans are tailored, transparent, and discussed in detail before you make any decisions or travel arrangements.

Conditions & Specialisations

Conditions Treated by Dr. Kunjahari Medhi

Blood Cancer (Leukemia & Lymphoma)

AML, CML, CLL, ALL, Hodgkin & Non-Hodgkin Lymphoma, Multiple Myeloma — treated with chemotherapy, targeted therapy & BMT.

Bone Marrow Transplant (BMT)

Autologous, allogeneic, and haplo-identical BMT for leukemia, lymphoma, aplastic anemia, and inherited blood disorders.

CAR T-Cell Therapy

Cutting-edge immunotherapy using genetically modified T-cells for blood cancers that have relapsed after standard treatments.

Thalassemia & Sickle Cell Disease

Curative BMT for thalassemia major and sickle cell anemia in children and adults. Low-cost programs available across India.

Aplastic Anaemia

Both immunosuppressive therapy and stem cell transplantation for severe and very severe aplastic anemia, including pediatric cases.

Stem Cell Transplant for MS

HSCT (Hematopoietic Stem Cell Transplant) for aggressive Multiple Sclerosis — a disease-modifying treatment available in India.

Pediatric Haematology

Expert care for childhood leukemia, thalassemia, ITP, and inherited bone marrow failure syndromes.

Myelodysplastic Syndrome (MDS)

Diagnosis and treatment of bone marrow failure and pre-leukemia syndromes with modern protocols.

Hemophilia & Bleeding Disorders

Comprehensive management of hemophilia A & B, Von Willebrand disease, platelet disorders, and coagulopathies.

Procedures & Techniques

Procedures & Expertise

Allogeneic Bone Marrow Transplant (Allo-BMT)

The most complex and potentially curative form of BMT where stem cells come from a matched donor. Used for leukemia, aplastic anemia, and inherited blood disorders.

  • HLA-matched sibling and unrelated donor transplants
  • Haplo-identical (half-match) transplants
  • Reduced-intensity conditioning for older patients
  • Comprehensive GVHD prevention and management
Expected Outcome: Long-term remission in 60-80% of suitable patients
Autologous Stem Cell Transplant (Auto-SCT)

Patient's own stem cells are harvested and reinfused after high-dose chemotherapy. Used for multiple myeloma and relapsed lymphomas.

  • Peripheral blood stem cell collection
  • High-dose melphalan for multiple myeloma
  • BEAM conditioning for lymphoma
  • Rapid recovery with minimal GVHD risk
Expected Outcome: Deep remission and extended progression-free survival
CAR T-Cell Therapy

Revolutionary immunotherapy where the patient's own T-cells are genetically reprogrammed to attack cancer cells.

  • CD19-targeted CAR T for B-cell lymphomas and ALL
  • BCMA-targeted CAR T for multiple myeloma
  • Cytokine release syndrome management
  • Available for patients who relapsed after 2+ lines of therapy
Expected Outcome: Complete remission in 40-70% of relapsed/refractory cases
BMT for Thalassemia & Sickle Cell Disease

The only curative treatment for beta-thalassemia major and sickle cell disease through allogeneic stem cell transplantation.

  • Best outcomes in children with minimal organ damage
  • Low-cost BMT programs available across India
  • Dedicated thalassemia transplant protocols
Expected Outcome: Disease-free survival of 85-90% in young Class I & II patients
Chemotherapy & Targeted Therapy

Personalised chemotherapy and next-generation targeted agents for lymphoma, leukaemia, and related disorders.

  • CHOP, R-CHOP, DHAP, ICE protocols
  • Tyrosine Kinase Inhibitors (TKIs)
  • Monoclonal antibody therapy
  • Intrathecal chemotherapy
Expected Outcome: Remission in majority of newly diagnosed blood cancer patients
Patient Voices

What Our International Patients Say

Measured Results

Clinical Outcomes & Success Metrics

>90%Procedure success rate in suitable patients
50+Countries whose patients have received care
4.8 / 5Average patient satisfaction rating
24-48 hrsTime to receive treatment plan after sharing reports
2-3 weeksTypical time from first contact to travel-ready
60-80%Cost savings vs. USA / UK for equivalent treatment
Free Consultation

Get Free Expert Opinion from Dr. Kunjahari Medhi

Send your medical reports and get a personalised treatment plan. The team reviews cases from 50+ countries and responds within 24 hours.

  • Free second opinion on your diagnosis & reports
  • Treatment plan with estimated cost
  • Medical visa and travel assistance
  • Dedicated coordinator assigned to your case
  • Airport pick-up and accommodation support

Get Free Doctor Opinion

Our team responds within 24 hours

Your information is private & secure
Common Questions

Frequently Asked Questions when planning Hematology Treatment with Dr Kunjahari Medhi in India by International Patients

How do I book a consultation with Dr Kunjahari Medhi for Hematology Treatment in India?
Send your medical reports via WhatsApp or our contact form. Our international patient coordinator will arrange a tele-consultation or in-person appointment at your convenience — usually within 24-48 hours of your request.
Does Dr. Kunjahari Medhi treat international patients?
Yes. Dr. Kunjahari Medhi regularly treats patients from over 50 countries. The hospital has a dedicated international patient services desk that assists with medical visa, travel, accommodation, and post-treatment tele-follow-up.
Can I get a second opinion remotely?
Absolutely. Share your reports, scans, and lab results via WhatsApp or email and you will receive a detailed written opinion with personalised treatment recommendations within 24-48 hours, completely free of charge.
How much can I save compared to my home country?
Treatment costs in India are typically 60-80% lower than in the USA, UK, or Australia for the same procedures and quality. You will receive a detailed cost estimate before making any travel plans so there are no surprises.
Is visa assistance available for India?
Yes. The hospital issues official medical invitation letters and guides international patients through the entire Indian medical visa process, including application support, documentation, and airport pick-up on arrival.
What languages does the support team speak?
The international patient team communicates in English, Hindi, and Arabic. Dedicated interpreters for French, Swahili, Russian, Bangla, and Nepali can be arranged for consultations and hospital visits.
Does the hospital accept international health insurance?
Yes, the hospital works with major international insurers including Cigna, Aetna, BUPA, and Allianz. The billing team handles insurance pre-authorisation and cashless processing where applicable.
Can family members stay with the patient during treatment?
Yes. Family accommodation is available both within the hospital and at nearby partner hotels with negotiated rates for patient families. Our coordinator will help arrange this before your arrival.
What post-treatment follow-up is provided?
Dr. Kunjahari Medhi's team provides structured tele-follow-up, digital prescription management, and coordination with your local doctor once you return home. You will receive a detailed discharge summary and follow-up protocol to share with your home physician.
What is the consultation fee for international patients?
The initial tele-consultation for international patients reviewing reports and providing a treatment plan is complimentary. Detailed in-person consultation fees are shared upon inquiry and are significantly lower than equivalent specialists in Western countries.

Get Treatment Plan from Dr. Kunjahari Medhi

Share your reports and receive a personalised treatment recommendation within 48 hours — at no cost.

⚠️Disclaimer: The information provided on this page is for educational purposes only and does not replace medical advice, diagnosis, or treatment.
Get Doctor Opinion Book Appointment